Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
51 studies found for:    " June 02, 2010":" July 02, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: The PrePex a novel device for adult male circumcision
2 Recruiting Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies
Condition: HIV Infection
Interventions: Behavioral: Linkage-to-Care Component: Financial Incentive (FI);   Behavioral: Linkage-to-Care Component: Standard of Care (SOC);   Behavioral: Viral Suppression Component: FI;   Behavioral: Viral Suppression Component: SOC;   Behavioral: Prevention for Positives Component: Counseling and SOC;   Behavioral: Prevention for Positives Component: SOC
3 Active, not recruiting HIV/AIDS, Severe Mental Illness and Homelessness
Conditions: HIV;   AIDS
Intervention: Behavioral: Skills Building - Motivational Interviewing
4 Completed Epidermal Nerve Fiber Density, Fat and Mitochondrial Parameters in Thai HIV+ Patients on d4T and HIV- Patients
Condition: HIV
Intervention:
5 Completed
Has Results
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
Conditions: HIV Seroconversion;   Stimulant Abuse
Intervention: Drug: Truvada
6 Completed Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring
Condition: HIV Infections
Interventions: Drug: dapivirine;   Drug: placebo
7 Unknown  Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention
Conditions: HIV Infections;   Hepatitis;   Sexually Transmitted Infections
Interventions: Behavioral: Traditional Prevention;   Behavioral: Web-based Prevention
8 Completed Pharmacokinetics of Low Dose Raltegravir
Condition: HIV Infections
Intervention: Drug: raltegravir
9 Completed HIV Testing in Non-traditional Settings Study
Condition: HIV
Interventions: Other: Questionnaire;   Other: Focus Group Discussion;   Other: HIV test (serum or salivary);   Other: Semi-structured telephone interview
10 Active, not recruiting Autologous Transplant in HIV Patients (BMT CTN 0803)
Conditions: Lymphoma;   HIV
Intervention: Procedure: Autologous transplant
11 Completed The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers
Conditions: HIV;   Fenofibrate;   Protease Inhibitors;   Hypertriglyceridemia;   Glucuronosyltransferase
Interventions: Drug: Fenofibrate;   Drug: Ritonavir;   Drug: Lopinavir/Ritonavir
12 Completed
Has Results
HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.
Conditions: HIV/AIDS;   Sexually Transmitted Infections
Intervention: Behavioral: RESPECT-2 Counseling
13 Completed The Effects of Spirulina Platensis on Insulin Resistance in HIV-infected Patients
Conditions: Insulin Resistance;   HIV/AIDS
Interventions: Dietary Supplement: Spirulina platensis;   Dietary Supplement: Soya bean
14 Unknown  Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation
Conditions: Renal Function;   HIV Infection
Intervention: Other: Tc99mDTPA renal clearance
15 Completed Protective Efficacy Against Tuberculosis (TB) Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: MVA85A/AERAS-485;   Biological: Candida albicans Skin Test Antigen
16 Completed
Has Results
Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects
Condition: HIV Infections
Interventions: Biological: TUTI-16 (0.2mg);   Biological: TUTI-16 (1.0 mg)
17 Unknown  Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz
Condition: HIV Infections
Intervention: Drug: generic FDC of TDF/3TC/EFV
18 Completed Metabolic and Psychological Changes Associated With Menopause Among Women With HIV
Conditions: HIV Infections;   Menopause
Intervention:
19 Unknown  Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: LPV/r
20 Completed A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761;   Drug: Simvastatin;   Drug: Atorvastatin;   Drug: Rosuvastatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years